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Purpose of the Report 
 
The following is a descriptive report of invasive Haemophilus influenzae cases as 
reported to the Maricopa County Department of Public, Division of Disease Control, 
Office of Epidemiology during the years 2000-2007.  The report will encompass the 
following: 
• A brief overview of the Haemophilus influenzae bacterium and its characteristics 
• Methodology 
• Case demographics, serotype data, and disease trends 
• A discussion addressing data quality and timeliness of reporting  
 
The purpose of this report is twofold:  first to define the illness and its trends in Maricopa 
County during this time period and second to identify potential areas of improvement in 
data quality.  
 
Overview of Haemophilus influenzae 
 
Etiologic Agent 
 
Haemophilus influenzae is a gram negative coccobacilli bacterium which is characterized 
as being capsulated or unencapsulated.  Among the organisms having a polysaccharide 
capsule there are six serotypes designated as a-f with serotype b being the most clinically 
significant.  Unencapsulated organisms, those not having a polysaccharide capsule, are 
categorized as non-typeable.  
 
 
Figure1. Haemophilus influenzae bacterium 
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Clinical Description 
Haemophilus influenzae disease manifests within various locations in the body causing 
infections such as the more prevalent bacteremia, meningitis, epiglottitis, and pneumonia 
to the less prevalent endocarditis.  In the United States complications from Haemophilus 
influenzae type b (Hib) include fatalities in 3-6% of the cases and as many as 20% of the 
cases have permanent hearing damage or other long term health concerns (Centers for 
Disease Control and Prevention [CDC], 2008).  Symptoms of H. influenzae infections are 
generalized and dependent upon where it has manifested in the body.  The generalization 
of symptoms may present obstacles to diagnosing the disease.  Although, Hib is the most 
clinically significant, the other serotypes are just as adept at causing illness.   
   
Reservoirs 
 
The reservoir for this organism is the human respiratory tract.  During the pre-vaccine 
era, the organism could be isolated from the nasopharynx of children that were often 
asymptomatic indicating colonization rather than infection.  A recent study concluded 
that infants who are immunized are less likely to become colonized than those who have 
not been immunized.  The authors determined that an association existed between levels 
of serum antibodies against Hib and the likelihood of being colonized (Fernandez, J., 
Levine, O., Sanchez, J., Balter, S., LaClaire, L., & Feris, J., 2000).   
 
Modes of Transmission 
The mode of transmission occurs via person to person through nasopharyngeal droplets 
or direct contact with respiratory tract secretions.  Entry into uninfected individuals 
occurs through the nasopharynx as a result of contact with nasopharyngeal droplets of an 
infected person or one who is a carrier.  Contact includes the sharing of utensils, 
coughing or kissing.   
 
 
Incubation Period and Period of Communicability 
 
The symptoms of H. influenzae usually occur within one to four days after exposure 
(American Academy of Pediatrics, 2006).  Conclusive secondary attack rates have not 
been established for either household members or children that attend daycare.   
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Epidemiology 
The World Health Organization ([WHO], 2005) reports that worldwide Haemophilus 
influenzae type b (Hib) is responsible for approximately 3 million cases and 386,000 
deaths.  These cases primarily occur in developing countries where the disease is not 
readily recognized, antibiotic treatment is scarce and a vaccine is not available.  WHO 
(2008) reports that as of 2007, many African and Asian countries still do not have an 
available Hib vaccine.          
 
The vaccine was first used in the United States in 1988.  The first vaccine was licensed 
for children 18-59 months old and two years later the second vaccine was licensed for use 
in infants.  During the nine years following the initiation of Hib vaccinations the 
incidence in children less than five years old declined by 99% (CDC, 1998) from 34 per 
100,000 (CDC, 1998) to the current rate of 1 case per 100,000 in children less than five 
years old (CDC, 2008).  New standards established in CDC’s Healthy People 2010 
indicate that the goal is to eliminate infections in children under the age of five years old 
by creating a herd immunity effect. 
 
The Centers for Disease Control and Prevention is monitoring the progress of this goal by 
performing enhanced surveillance in ten states representing approximately 36 million 
individuals (CDC Active Bacterial Core Surveillance, 2008).     
 
The following is a graph of U. S. Hib rates in children less than five years old for years 
2000-2007. 
 
Graph1.  U.S. Haemophilus influenzae serotype b Rates in Ages 0-4 Years old for 
Years 2000-2007 
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  CDC Active Bacterial Core Surveillance Reports for Years 2000-2007 
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The Centers for Disease Control and Prevention Active Bacterial Core Surveillance 
(ABC) projects the number of cases and fatalities for the U.S. based on their  
areas of enhanced surveillance.  Table 1 below represents past case projections and the 
case fatality rates.  As a comparison, the actual number of cases reported to the Centers 
for Disease Control and Surveillance is presented in Table 2.  It should be noted that the 
number of reported cases has steadily increased over the years.  This increase in reported 
cases is likely due to the enhanced active surveillance in the project areas.  Although the 
number of reported cases has been increased, it is still assumed that many cases are not 
being reported and this account for the discrepancy between the reported and the 
estimated number of cases.  
 
 
Table1. U.S. Projected Number of invasive Haemophilus influenzae Cases and 
 Case Fatality Rates for 2000-2007 
  
Rates are per 100,000 based on the 2000 U.S. Census Projected Population   
Provided by the Active Bacterial Core Surveillance (ABC) 
 
Table2.  Number of U.S. Reported invasive Haemophilus influenzae Cases and 
Rates for 2000-2007 
 2000* 2001* 2002* 2003* 2004* 2005* 2006* 2007** Total 
# of 
Cases 
1,398 1,597 1,743 2,013 2,085 2,304 2,496 2,541 16,177 
Rate 0.5 0.6 0 .6 0.7 0 .7  0.8  0.8  0.8 0 .7 
    Rates are per 100,000 based on the 2000 U.S. Census Projected Population  
  *CDC. Summary of notifiable diseases, United States, 2007 
**CDC. Summary of notifiable diseases, United States, 2008 
 
 
Social Risk Factors 
 
Social risk factors for Hib include socioeconomic status, household size, and ethnicity.  
United States statistics indicate Native Americans and Alaskan Natives are more likely to 
be diagnosed with a Hib than the rest of the population (CDC, 2008).  This increased 
diagnosis rate is likely due to lower vaccination rates among these groups.  Finally, the 
 2000 2001 2002 2003 2004 2005 2006 2007 Total 
# of 
Cases 
3400 3800 3850 3725 4150 4200 4800 4700 32,625 
Rate 1.2 1.3 1.3 1.3 1.4 1.4 1.6 1.6 1.4 
# of 
Deaths 
700 625 600 550 725 600 700 700 5200 
Case 
Fatality 
Rate 
20.6% 16.4% 15.6% 14.8% 17.5% 14.3% 14.6% 14.9% 15.9% 
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greatest risk factor is age, with most cases being infected under the age of five years old 
and a peak age of diagnosis occurring at six to seven months old.  
 
 
Prevention 
 
There are two manners in which natural immunity can be acquired.  First, immunity is 
acquired maternally through breastfeeding or the placenta.  Second, immunity is thought 
to occur as a result of natural exposure to the organism.  Today, in developed countries, 
immunity to Hib is more commonly acquired through a series of vaccinations.  As 
historically Hib was the most clinically significant serotype of the bacterium 
Haemophilus influenzae currently is the only serotype that is vaccine preventable.  
 
The following table is the current vaccination schedule for Hib as recommended by the 
Advisory Committee on Immunization Practices (ACIP) (CDC, 1991).   
 
Table3. ACIP-Recommended Haemophilus influenzae type b (Hib) Routine 
Vaccination Schedule 
  * polyribosylribitol phosphate conjugated to tetanus toxoid 
** polyribosylribitol phosphate  conjugated to an outer-membrane protein of Neisseria  meningitidis 
 
 
Chemoprophylaxis 
 
Control measures include providing chemoprophylaxis to exposed unimmunized or 
incompletely immunized household, childcare, or nursery contacts. 
 
  
Haemophilus influenzae Surveillance in Maricopa County for 2000-2007  
 
As directed by Arizona Administrative Code (AAC) R9-6-333 invasive Haemophilus 
influenzae must be reported within five days after diagnosis and case has been 
established.  A potential case is defined and classified as follows: 
      Clinical Description  
 Invasive disease due to Haemophilus influenzae may produce any of several clinical 
syndromes including meningitis, bacteriemia, epiglottitis, or pneumonia 
 
       Laboratory Criteria for Diagnosis  
                       Isolation of H. influenzae from a normally sterile site  
      Case Classification  
Confirmed: A clinically compatible illness that is culture-confirmed  
Probable: A clinically compatible illness with detection of H. influenzae type b antigen in    
                                       cerebrospinal fluid.  
      
Vaccine 2 Months 4 Months 6 Months 12-15 Months 
PRP-T* Dose 1 Dose 2 Dose 3 Booster 
PRP-OMP** Dose 1 Dose 2  Booster 
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In addition to reporting the case, Arizona Administrative Code mandates that all 
Haemophilus influenzae isolates be submitted to the Arizona State Public Health 
Laboratory for serotyping.   
 
 
Case Investigation Methodology 
 
A total of 651 Communicable Disease Reports for H. influenzae were received by the 
Maricopa County Department of Public Health during the years 2000-2007.  Three 
hundred of these reports were ruled out due to one or more of the following reasons:  
specimen source not being a sterile site, out of jurisdiction, duplicate report received or 
isolate being of a different Haemophilus species.  Five cases were identified through 
death certificates and eliminated due to an investigation not being completed.  The 
remaining cases included in the analysis consists of those classified as probable (2) and 
confirmed (344) for a total of 346 meeting the case definition during the years 2000-
2007.  Graphs 2 and 3 represent the number and rates of cases reported by years. 
 
Graph2.  Number of Haemophilus influenzae Cases in Maricopa County by Year of 
Report for 2000-2007 (N=346) 
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Graph3.  Maricopa County Haemophilus influenzae Rates by Year of Report for 
Years 2000-2007 (N=346) 
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   Rates are per 100,000 based on U.S. 2000-2007 Census Data for Maricopa County 
 
Cases are typically reported by health care providers, with 81% (280) of cases coming 
from providers.  Laboratories reported 19% (66) of cases.  Graph 4 summarizes the 
number of cases received during this time period and the sources of report by year of 
disease onset.  The modes of reporting used by healthcare providers are summarized in 
Graph 5.  The graph indicates that the use of mail to report cases is rapidly declining due 
to quicker methods such as the use of electronic reporting, telephone, and fax.     
   
Graph4. Maricopa County Sources of H. influenzae Reports for Years 2000-2007 
(N=346) 
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Graph5.  Modes of Reporting Used by Healthcare Providers for Haemophilus 
influenzae in Maricopa County for Years 2000-2007 (N=280) 
 
 
 
                                                 
 
Case Investigation Procedure 
 
Once a case is received by the Office of Epidemiology, a Community Health Nursing 
(CHN) staff member will begin investigating the case immediately.  The investigation 
includes confirming the diagnosis, identifying personal contacts, providing 
chemoprophylaxis if necessary and implementing control measures as needed.  The 
following flowchart is a diagram of the steps implemented to complete an investigation.   
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Diagram 1.  Case Investigation Procedures for H. influenzae
No 
Yes
         No
Yes
Case received from laboratory/ 
health care provider/ Other 
CHN will contact the Lab to 
obtain a hard copy of the lab 
report 
Positive H. 
Flu report? Rule Out No Further 
Action Taken
Contact submitting 
physician or health care 
facility to obtain patient 
information
Call Patient for Details 
Including Possible Onset and 
Contacts.  Provide education 
Determine if there 
was close contact 
with another person 
with in seven days 
post onset 
End of Investigation
Determine if Anitibiotics or 
Vaccination to Hib is Necessary
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Epidemiologic Trends in Maricopa County, 2000-2007 
 
The rate of reported infections remained steady between the years 2000-2007.  The most 
cases were reported in the year 2005, and the highest case fatality rates occurred in 2003 
and 2005.  Of the 346 cases reported during 2000-2007 there were 18 deaths resulting in 
a case fatality rate of 5.2% (Refer to Table 4).   
 
Table4. Number of invasive Haemophilus influenzae Cases and Case Fatality Rates 
for Years 2000-2007 in Maricopa County 
 2000 2001 2002 2003 2004 2005 2006 2007 Total 
# of 
Cases 
33 35 46 39 42 59 47 45 346 
Rate* 1.1 1.1 1.4 1.1 1.2 1.6 1.2 1.2 1.2 
# of 
Deaths 
0 1 2 5 2 5 3 0 18 
Case 
Fatality 
Rate 
0.0% 2.9% 4.3% 12.8% 4.8% 8.5% 6.4% 0.0% 5.2% 
*Rates are per 100,000 based on 2000-2007 U.S. Census Populations for Maricopa County  
 
 
 
 
Seasonality 
 
Haemophilus influenzae type b has two peak seasons during the year that were more 
prominent before the vaccine era began.  These peaks reportedly occurred March thru 
May and September thru December.  Graph 6 is a representation of Maricopa County’s 
cases by month.      
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Graph6. Maricopa County Haemophilus influenzae Cases by Month of Onset for 
Years 2000-2007 (N=346) 
 
 
 
Distribution by Serotypes 
 
During the years 2000-2007 the H. influenzae organism isolated most often from sterile 
sites were non-typeable isolates (162 specimens).  Serotype c was isolated from 2 
specimens making it the serotype that was the least often isolated.  Graph 7 shows the 
contribution each serotype made to the 346 cases. 
 
Graph7. Number of Reported Haemophilus influenzae Serotypes for Years 2000-
2007 in Maricopa County (N=346) 
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Two hundred and eighty-nine reported cases were categorized as having 
bacteremia/sepsis.  Meningitis was the second most common syndrome with 44 cases 
reported.  Table 5 illustrates the association between serotypes and diagnosis.    
  Table5.  Syndromes by Haemophilus influenzae Serotypes for Years 2000-2007 in 
Maricopa County 
  Bacteremia/Sepsis Meningitis Pneumonia Unspecified Total 
A 33 15 0 0 48 
B 15 2 0 0 17 
C 2 0 0 0 2 
D 9 0 0 0 9 
E 21 0 2 0 23 
F 32 5 3 0 40 
Nontypeable 140 19 3 0 162 
Unknown 37 3 3 2 45 
Total 289 44 11 2 346 
 
 
Graph 8 is a representation of serotypes by year of report.  Each year during the years 
2003-2006 the number of non-typeable H. influenzae organisms was greater than all other 
serotypes combined.  
 
Graph8. Haemophilus influenzae Serotype Percentages for Years 2000-2007 in 
Maricopa County (N=346) 
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Case Demographics 
 
Cumulatively, 52% of the cases were female, 58% were white, and the age group most 
represented was 0-4 years old (26%).  Serotype b accounted for 5% of the total cases and 
had an infection rate of 0.18 per 100,000 in those less than five years old.  
 
Graph 9 represents the case rates by race/ethnicity and year of report.  The graph 
indicates that the rates for Native Americans are much greater in most years than any 
other group. 
 
Graph9. Rates for Maricopa County Haemophilus influenzae Cases by Race for 
Years 2000-2007   
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*Rates are Per 100,000 based on 2000-2007 U.S. Census Populations for Maricopa County 
 
 
Graph 10 is a representation of the number of cases by age groups.  It indicates that the 
very young and those sixty-five and older are more likely to be diagnosed with invasive 
H. influenzae. 
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Graph10. Maricopa County Haemophilus influenzae Cases by Age Groups for 
Years 2000-2007 (N=346) 
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Graph 11 presents the rates of reported cases for each age group.  The graph demonstrates 
a steady increase between the ages of 55 and 84 years old but beyond this age there is a 
steep increase. 
 
Graph11. Rates for Haemophilus influenzae Cases in Maricopa County by Age 
Group for Years 2000-2007 
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  Rates per 100,000 according to the 2000-2007 U.S. Population Census for Maricopa County 
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Graph 12 presents the rates of cases by gender and year of report.  The rates demonstrate 
that in most years females exceed males.  The exception is 2001 when the two were 
equal. 
 
 
Graph12. Maricopa County Haemophilus influenzae Rates by Gender for Years 
2000-2007 (N=346) 
 
 
 Rates per 100,000 per 2000-2007 U.S. Population Census for Maricopa County 
 
 
 
Outcome 
 
The case fatality rate (CFR) for Haemophilus influenzae during the years 2000-2007 was 
5.2%.  Individuals who were four years old or less and those who were over the age of 65 
were most likely to succumb to the infection representing 22.2% (1.6% CFR) and 50.0% 
(2.6% CFR) of the fatal cases respectively.  Graph 13 is a representative of outcome 
percentages.   
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Graph13.  Maricopa County Haemophilus influenzae Cases by Outcome for Years 
2000-2007    (N=346) 
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Haemophilus influenzae isolates classified as non-typeable were more likely to be 
associated with a fatal case than any other serotype, 44.4%, and had a case fatality rate of 
2.3%.  Reportedly, none of the cases diagnosed with an invasive disease caused by 
serotypes c or d resulted in a fatality (Graph 14).  
 
Graph14. Maricopa County Haemophilus influenzae Case Fatality Rates by 
Serotypes for Years 2000-2007 
      
 
*Expressed as a percentage of total cases 
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Graph 15, represent the association between outcome and age.  It should be noted that no 
deaths were reported for individuals who were within the age range of 5-34 years old 
during the years 2000-2007.   
   
Graph15.  Case Fatality Rates for Maricopa County Haemophilus influenzae Cases 
by Age Groups for Years 2000-2007 (N=346) 
 
   
 
 
Graph 16 is a representation of the number of deaths occurring by year the case was 
reported.  In 2003 and 2005, a Haemophilus influenzae infection was associated with five 
deaths in each year.  
  
Graph16.  Maricopa County Haemophilus influenzae Cases with a Fatal Outcome 
by Year Case was Reported and Death Occurred (N=18)* 
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 * No deaths were reported for years 2000 and 2007 
 
 
 
Vaccinations 
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 Twenty-eight cases reported being vaccinated for Haemophilus influenzae serotype b 
(Hib) either completing the vaccine series (43.0%) or partially completing the series, 
(57.0%).  The most common serotype isolated from these twenty-eight cases was 
serotype a which made up 43.0% of total cases.   
   
According to the data collected during the investigations, whites were more likely to 
report being vaccinated.  Table 6 represents the percentage of children reportedly 
vaccinated, during the investigation of Haemophilus influenzae cases, by race/ethnicity.  
 
 
Table6. Maricopa County Haemophilus influenzae serotype b vaccinated cases by 
race for years 2000-2007   
Race  Vaccinated  
Percentage of 
Cases 
White  13 46.0% 
Hispanic 3 11.0% 
Black 5 18.0% 
Unknown 7 25.0% 
Total 28 100.0% 
 
 
Haemophilus influenzae serotype b 
 
Seventeen cases were diagnosed with Haemophilus influenzae serotype b.  Four of the 
seventeen cases were diagnosed in children under five years old.  CDC estimates that the 
national rate of infection for children under five years old is less than 1 per 100,000 and 
Maricopa County is similar to that of the rest of U.S with a rate of 0.2 per 100,000.  The 
following graphs (17, 18 and 19) and Table 7 exemplify demographics specific to these 
cases.   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph17. Maricopa County Haemophilus influenzae serotype b cases by Gender for 
Years 2000-2007 (N=17)  
    
21
0
1
2
3
4
5
6
7
8
9
10
Male Female
Gender
N
u
m
b
e
r 
o
f 
C
a
s
e
s
 
 
 
 
 
Graph18. Maricopa County Haemophilus influenzae serotype b Cases by Race for 
Years 2000-2007 (N= 17) 
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Table7. Maricopa County Haemophilus influenzae serotype b Cases by Race and 
Age Rates (per 100,000) 
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Age in Years  White Hispanic Black 
Native 
American Total* 
0-4 .10 (1) .20 (2) 0 (0) 2.26 (1) .18 (4) 
5-14 0 .0(0) 0 .0(0) 0.0 (0) 0.0 (0) 0 .0(0) 
15-19 0.0 (0) 0.0 (0) 0.0 (0) 0 .0(0) 0.0 (0) 
20-34 .03 (1) 0 .0(0) .41 (1) .77 (1) .05 (3) 
35-44 0.0 (0) 0.0 (0) 0 .0(0) 0.0 (0) 0.0 (0) 
45-54 0.0 (0) 0 .0(0) 0.0 (0) 0.0 (0) 0.0 (0) 
55-64 .10 (2) .32 (1) 0.0 (0) 0.0 (0) .12 (3) 
65-84 .21 (5) 0 (0) 1.77 (1) 0 (0) .22 (6) 
85+ .27 (1) 0 (0) 0 (0) 0 (0) .25 (1) 
TOTAL** .06 (10) .04 (3) .19 (2) .46 (2) .06 (17)*** 
    *Total population includes all races and ethnicities ie number of cases divided by county population for stated age group    
        multiplied by 100,000 
   **Specific to cases in stated race/ethnicity ie number of cases within race divided by county population for stated race  
***Total population including all races and age groups ie number cases divided by county population   
 (x)  Number of cases 
   
 
 
 
 
Graph19. Maricopa County Haemophilus influenzae Type b Cases by Age for Years 
2000-2007 (N=17) 
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Haemophilus influenzae Data Quality in Maricopa County, 
2000-2007 
 
Case data are collected from health care provider and laboratory reports and subsequent 
county investigations.  The quality of disease surveillance is determined by the quality of 
the collected data.  One method for assessing data quality is to measure the number of 
cases with missing or incomplete data that are present in the database.  The following 
table exemplifies the number of Haemophilus influenzae cases that have missing or 
incomplete data for selected variables.  Table 8 shows that basic patient demographic 
information is being obtained which enables the county’s community health nurses to 
begin an investigation.  The table also illustrates that the ever important information 
regarding pregnancy is being obtained 97.7% of the time for females between the ages of 
14-55 years old.  Finally, the serotype was identified for 87.0% of the cases.   
     
 
Table8.  Maricopa County Haemophilus influenzae Data Quality Analysis for Years 
2000-2007 
Field Analyzed 
Total 
Number of 
Cases 
Reported 
Total 
Number of 
Cases with 
Field 
Complete 
% Of 
Cases with 
Field 
Complete 
Total 
Number 
of Cases 
with 
Field 
Missing 
% of Cases 
with Field 
Missing 
Last Name 346 346 100.0% 0 0.0% 
First Name 346 346 100.0% 0 0.0% 
Date of Birth 346 346 100.0% 0 0.0% 
Gender 346 346 100.0% 0 0.0% 
   Male 181 181 100.0% 0 0.0% 
   Female 165 165 100.0% 0 0.0% 
Complete Patient 
Address 346 336 97.1% 10 2.9% 
Outcome 
(Died/Survived) 346  300 86.7% 46 13.3% 
Race/Ethnicity 346 338 97.7% 8 2.3% 
Pregnant (Females 
between the ages of 
14-55 yrs.) 38 35 92.1% 3 7.9% 
Date of Diagnosis 346 339 98.0% 7 2.0% 
Date of Onset 346 315 91.0% 31 9.0% 
Date Report Received 346 346 100.0% 0 0.0% 
Reporting Source 346 330 95.4% 16 4.6% 
Serotype 346 301 87.0% 45 13.0% 
Supplemental 
Longform  
Completed 346 303 87.5% 43 12.4% 
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Investigation Timeliness in Maricopa County, 2000-2007 
 
Ideally, infectious disease cases should be reported and the investigation completed 
before the end of the known incubation period so that further spread of the disease can be 
avoided.  Unfortunately, this is not always possible.  Nevertheless, it is still important for 
the case to be reported and the investigation to occur in a timely manner.  The following 
graph represents the median number of days for each step of the case identification and 
investigation for the years 2000-2007.  Cases for which a definite end or beginning of 
investigation could not be determined or cases missing other pertinent dates such as onset 
of disease were omitted from the analysis, 103 (30%) cases.  The remaining cases used 
for this analysis represented 70% (243) of the confirmed cases.    
 
Graph20.  Median Length of Days from Onset of Disease to Completion of Case 
Investigation for Maricopa County Haemophilus influenzae Cases for Years 2000-
2007 (N=243) 
 
 
 
 
 
 
Current and future research 
 
Current literature illustrates that although strides have been made in the developed world 
to effectively decrease Hib there are still unresolved issues.  For instance, In the United 
States the incidence rate has dropped significantly due to the inception of the vaccine 
(Centers for Disease Control and Prevention, 2008) yet this period of enjoyment could be 
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short-lived due to a genetic adaptation of the organism allowing it become more virulent 
and causing vaccine failures (Cerquetti et al, 2005).  
 
Such issues also include the rise in the number of the unencapsulated, non-typeable, form 
of the bacteria isolated from sterile sites.  In a study researchers, using data from several 
states, determined that non-typeable serotypes were more commonly isolated from sterile 
sites than any other serotype (Dworkin, Park, & Borchardt, 2007).  Although Maricopa 
County’s data was not apart of this study the results are consistent with data presented in 
previous sections of this summary.  Future studies should determine if the unencapsulated 
organism has adapted to be more virulent or was its magnitude overlooked in the 
beginning.  An intriguing question for future consideration is now that H. influenzae 
serotype b is somewhat contained in the United States will it become necessary to 
increase surveillance and create a vaccine for the emerging unencapsulated form of H. 
influenzae. 
 
As the data for Maricopa County and past studies have shown African Americans and 
Native Americans/Alaskan Natives are disproportionately affected by H. influenzae 
primarily type b.  Two thoughts abound as to the cause one is that African Americans and 
Native Americans/Alaskan Natives are genetically more susceptible and the other is that 
both groups are typically in lower socioeconomic strata causing them to reside in close 
confined areas (Rust & Cavaliere, 2006).  Studies have yet proved, sufficiently, either 
thought therefore more research is needed in this area to find the cause.  
 
Conclusions 
 
1. The rate of children less than five years old diagnosed in Maricopa County 
between the years 2000-2007 with Haemophilus influenzae type b was less than 
the US national rate for the same age group and time period.  In fact, Maricopa 
County’s rate is close to the U.S. Healthy People 2010 goal.    
 
2. The majority of Haemophilus infections presented as bacteremia/sepsis 
 
3.  The majority of infections that are caused by Haemophilus influenzae were non-  
      typeable, these organisms were responsible for more deaths than any other   
      serotype. 
 
4. Individuals most commonly infected with Haemophilus influenzae, all serotypes 
and non-typeable, were over the age of sixty-five and those less than five years 
old.   
 
Future actions should include: 
  
• Increasing the quantity and quality of investigations by the Maricopa County 
Health Department 
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• Encouraging clinical laboratories to send more isolates to the Arizona State Public 
Health Laboratory for serotyping thereby decreasing the number of unknown 
serotype 
 
• Investigating the rising number of non-typeable isolates  
 
• Investigating the causes for the disproportionate number of cases among African 
Americans and Native Americans 
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A.  Seasonality 
 
A.  Table 1-Haemophilus influenzae by Month for Years 2000-2007  
 2000 2001 2002 2003 2004 2005 2006 2007 Total 
January 4 4 3 6 4 6 3 10  40 
February 3 5 6 8 13 12 7 3  57 
March 6 3 7 5 4 8 4 5 42 
April 4 1 4 3 2 5 4 5 28 
May 1 1 4 4 4 6 4 4 28 
June 1 0 0 3 1 2 7 3 17 
July 3 0 2 1 4 1 3 2 16 
August 1 3 3 0 3 2 4 1 17 
September 0 1 2 2 1 4 0 1 11 
October 3 4 6 2 1 5 1 3 25 
November 1 5 6 3 1 1 2 4 23 
December 6 8 3 2 4 7 8 4 42 
Total 33 35 46 39 42 59 47 45 346 
 
 
B.  Cases and Deaths of Invasive Haemophilus influenzae by Serotype  
 
 
 
B. Table 1-Cases and Death of Haemophilus influenzae by Serotype in 2000 
 Cases Deaths 
Serotype # % Rate #  %  
Case Fatality Rate 
(%) 
A 4 12.1 .13 0 0 0.0% 
B 2 6.1 .07 0 0 0.0% 
C 1 3.0 .03 0 0 0.0% 
D 3 9.1 .10 0 0 0.0% 
E 2 6.1 .07 0 0 0.0% 
F 2 6.1 .07 0 0 0.0% 
Non-
typeable 
11 33.3 .36 0 0 0.0% 
Unknown 8 24.2 .26 0 0 0.0% 
Total 33 100.0% 1.1 0 0.0% 0.0% 
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B. Table 2-Cases and Death of Haemophilus influenzae by Serotype in 2001 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
(%) 
A  4 11.4 .12 0 0.0 0.0% 
B  2 5.7 .06 0 0.0 0.0% 
C  0 0.0 0.0 0 0.0 0.0% 
D 1  2.9 .03 0 0.0 0.0% 
E 3  8.6 .09 0 0.0 0.0% 
F 7  20.0 .22 0 0.0 0.0% 
Non-
typeable 
16  45.7 .50 0 0.0 0.0% 
Unknown 2  5.7 .06 1 100.0 2.7% 
Total 35 100.0% 1.1 1 100.0% 2.7% 
 
 
 
 
B. Table 3-Cases and Death of Haemophilus influenzae by Serotype in 2002 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate  
A 10  21.7 .30 1 50.0 2.2% 
B  2 4.4 .06 0 0.0 0.0% 
C  0 0.0 0 0 0.0 0.0% 
D 3  6.5 .09 0 0.0 0.0% 
E 0  0.0 0 0 0.0 0.0% 
F  7 15.2 .21 0 0.0 0.0% 
Non-
typeable 
19  41.3 .58 1 50.0 2.2% 
Unknown 5 10.9 .15 0 0.0 0.0% 
Total 46 100.0% 1.4 2 100.0% 4.4% 
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B. Table 4-Cases and Death of Haemophilus influenzae by Serotype in 2003 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
A 4  10.3 .12 0 0.0 0.0% 
B  3 7.7 .08 1 20.0 2.56% 
C  0 0.0 0 0 0.0 0.00% 
D  0 0.0 0 0 0.0 0.00% 
E  0 0.0 0 0 0.0 0.00% 
F  6 15.4 .18 2 40.0 5.13% 
Non-
typeable 
 20 51.3 .59 1 20.0 2.56% 
Unknown  6 15.4 .18 1 20.0 2.56% 
 
Total 
39 100.0% 1.1 5 100.0% 12.82% 
 
 
 
 
 
 
 
 
 
 
B. Table 5-Cases and Death of Haemophilus influenzae by Serotype in 2004 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
A  6 14.3 .17 0 0.0 0.0% 
B  1 2.4 .03 0 0.0 0.0% 
C  0 0.0 0 0 0.0 0.0% 
D  0 0.0 0 0 0.0 0.0% 
E  1 2.4 .03 0 0.0 0.0% 
F  4 9.5 .11 0 0.0 0.0% 
Non-typeable  28 66.7 .80 1 50.0 2.4% 
Unknown  2 4.8 .06 1 50.0 2.4% 
Total 42 100.0% 1.2 2 100.0% 4.8% 
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B. Table 6-Cases and Death of Haemophilus influenzae by Serotype in 2005 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
A 5  8.5 .14 1 20.0 1.69% 
B  1 1.7 .03 0 0.0 0.0% 
C  0 0.0 0 0 0.0 0.0% 
D  0 0.0 0 0 0.0 0.0% 
E  9 15.3 .25 1 20.0 1.69% 
F  7 11.9 .19 1 20.0 1.69% 
Non-
typeable 
 28 47.5 .77 2 40.0 3.39% 
Unknown  9 15.3 .25 0 0.0 0.0% 
Total 59 100.0% 1.6 5 100.0% 8.47% 
 
 
 
 
 
 
 
 
B. Table 7-Cases and Death of Haemophilus influenzae by Serotype in 2006 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
A  5 10.6 .13 0 0.0 0.0% 
B  2 4.3 .05 0 0.0 0.0% 
C  0 0.0 0.0 0 0.0 0.0% 
D  0 0.0 0.0 0 0.0 0.0% 
E  3 6.4 .08 0 0.0 0.0% 
F  3 6.4 .08 0 0.0 0.0% 
Non-
typeable 
 26 55.3 .69 3 100.0 6.4% 
Unknown  8 17.0 .21 0 0.0 0.0% 
Total 47 100.0% 1.24 3 100.0% 6.4% 
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B. Table 8-Cases and Death of Haemophilus influenzae by Serotype in 2007 
 Cases Deaths 
Serotype # % Rate # %  
Case Fatality Rate 
A 10 22.2 .26 0 0.0 0.0% 
B  4 8.9 .10 0 0.0 0.0% 
C  1 2.2 .03 0 0.0 0.0% 
D  2 4.4 .05 0 0.0 0.0% 
E  5 11.1 .13 0 0.0 0.0% 
F  4 8.9 .10 0 0.0 0.0% 
Non-
typeable 
 14 31.1 .36 0 0.0 0.0% 
Unknown  5 11.1 .13 0 0.0 0.0% 
Total 45 100.00% 1.2 0 0.0% 0.0% 
 
 
 
 
 
B. Table 9-Cases and Death by Haemophilus influenzae by Serotype for 2000-2007 
 Cases Deaths 
Serotype # % Rate # % Case Fatality Rate 
A  48 13.9 .17 2 11.1 .58% 
B  17 4.9 .06 1 5.6 .29% 
C  2 .6 .01 0 0.0 0.0% 
D  9 2.6 .03 0 0.0 0.0% 
E  23 6.7 .08 1 5.6 .29% 
F  40 11.6 .14 3 16.7 .87% 
Non-
typeable 
 162 46.8 .58 8 44.4 2.31% 
Unknown  45 13.0 .18 3 16.7 .87% 
Total 346 100.0% 1.3 18 100.0% 5.20% 
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C.  Cases & Deaths of Haemophilus influenzae by Race/Ethnicity for Years 2000-
2007 
 
C. Table 1-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2000 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 16  48.5 .78 0 0.0 0.0% 
Hispanic 13  39.4 1.70 0 0.0 0.0% 
Black 1 3.0 .91 0 0.0 0.0% 
Asian/Pacific 
Islander 
0 0.0 0.0 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
3  9.1 6.30 0 0.0 0.0% 
Other 0  0.0  0 0.0 0.0% 
Unknown 0  0.0  0 0.0 0.0% 
Total 33 100.0% 1.07 0 0.0% 0.0% 
   *Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
 
 
C. Table 2-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2001 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 26 74.3 1.24 1 100.0 2.9% 
Hispanic 4 11.4 .48 0 0.0 0.0% 
Black  0 0.0 0.0 0 0.0 0.0% 
Asian/Pacific 
Islander 
 0 0.0 0.0 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
 3 8.6 5.91 0 0.0 0.0% 
Other  0 0.0  0 0.0 0.0% 
Unknown  2 5.7  0 0.0 0.0% 
Total 35 100.0% 1.09 1 100.0% 2.9% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
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C. Table 3-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2002 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 25  54.4 1.18 1 50.0 2.2% 
Hispanic  12 26.1 1.36 1 50.0 2.2% 
Black  4 8.7 3.30 0 0.0 0.0% 
Asian/Pacific 
Islander  
 0 0.00 0 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
 5 10.9 9.62 0 0.0 0.0% 
Other  0 0.0  0 0.0 0.0% 
Unknown  0 0.0  0 0.0 0.0% 
Total 46 100.0% 1.39 2 100.0% 4.4% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
 
 
 
C. Table 4-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2003 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 24  61.5 1.11 2 40.0 5.13% 
Hispanic  7 18.0 .75 1 20.0 2.56% 
Black  4 10.3 3.18 0 0.0 0.0% 
Asian/Pacific 
Islander 
 0 0.00 0 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
 2 5.1 3.76 1 20.0 2.56% 
Other  1 2.6  0 0.0 0.0% 
Unknown 1  2.6  1 20.0 2.56% 
Total 39 100.0% 1.15 5 100.0% 12.82% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
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C. Table 5-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2004 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 30  71.4 1.37 2 100.0 4.8% 
Hispanic  6 14.3 .61 0 0.0 0.0% 
Black  2 4.8 1.51 0 0.0 0.0% 
Asian/Pacific 
Islander 
 1 2.4 1.10 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
 3 7.1 5.46 0 0.0 0.0% 
Other  0 0.0  0 0.0 0.0% 
Unknown  0 0.0  0 0.0 0.0% 
Total 42 100.0% 1.20 2 100.0% 4.8% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
C. Table 6-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2005 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 31  52.5 1.38 0 0.0 0.0% 
Hispanic  18 30.5 1.71 2 40.0 3.39% 
Black  2 3.4 1.42 0 0.0 0.0% 
Asian/Pacific 
Islander 
1  1.7 1.01 1 20.0 1.69% 
Native 
American/Alaskan 
Native 
 4 6.8 6.92 1 20.0 1.69% 
Other  1 1.7  0 0.0 0.0% 
Unknown  2 3.4  1 20.0 1.69% 
Total 59 100.0% 1.62 5 100.0% 8.47% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
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C. Table7-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2006 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 30  63.8 1.31 2 66.7 4.3% 
Hispanic  11 23.4 .98 0 0.0 0.0% 
Black  2 4.3 1.33 0 0.0 0.0% 
Asian/Pacific 
Islander 
 1 2.1 .93 1 33.3 2.1% 
Native 
American/Alaskan 
Native 
 2 4.3 3.32 0 0.0 0.0% 
Other  1 2.1  0 0.0 0.0% 
Unknown 0  0.0  0 0.0 0.0% 
Total 47 100.0% 1.24 3 100.0% 6.4% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
C. Table 8-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2007 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 21  46.7 .91 0 0.0 0.0% 
Hispanic  12 26.7 1.01 0 0.0 0.0% 
Black  5 11.1 3.15 0 0.0 0.0% 
Asian/Pacific 
Islander 
 0 0.0 0 0 0.0 0.0% 
Native 
American/Alaskan 
Native 
 1 2.2 1.62 0 0.0 0.0% 
Other  3 6.7  0 0.0 0.0% 
Unknown  3 6.7  0 0.0 0.0% 
Total 45 100.0% 1.16 0 0.0% 0.0% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
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C. Table 9-Cases & Deaths of Haemophilus influenzae by Race/Ethnicity in 2000-
2007 
 Cases Deaths 
Race # % Rate* # %  
Case Fatality 
Rate** 
White 203  58.7 1.16 8 44.4 2.31% 
Hispanic  83 24.0 1.07 4 22.2 1.16% 
Black  20 5.8 1.89 0 0.0 0.0% 
Asian/Pacific 
Islander 
 3 .9 .41 2 11.1 .58% 
Native 
American/Alaskan 
Native 
 23 6.7 5.25 2 11.1 .58% 
Other  6 1.7  0 0.00 0.0% 
Unknown  8 2.3  2 11.1 .58% 
Total 346 100.0% 1.25 18 100.0% 5.20% 
*Individual race rates were calculated using race specific population; the total rate is based on the total   
     population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
D.  Cases & Deaths of Haemophilus influenzae in MC by Gender in 2000-2007 
 
 
D. Table 1-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2000 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 18 54.6 1.17 0 0.0 0.0% 
Male 15 45.5 .98 0 0.0 0.0% 
Total 33  100.0% 1.07 0 0.0% 0.0% 
  *Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
D. Table 2-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2001 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 17 48.6 1.06 1 100.0 2.9% 
Male 18 51.4 1.12 0 0.0 0.0% 
Total 35 100.0% 1.09 1 100.0% 2.9% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
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D. Table 3-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2002 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 25 54.4 1.52 1 50.0 2.2% 
Male 21 45.7 1.27 1 50.0 2.2% 
Total 46 100.0% 1.39 2 100.0% 4.4% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
D. Table 4-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2003 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 22 56.4 1.30 3 60.0 7.69% 
Male 17 43.6 1.00 2 40.0 5.13% 
Total 39 100.0% 1.14 5 100.0% 12.82% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
D. Table 5-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2004 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 24 57.1 1.38 2 50.0 4.8% 
Male 18 42.9 1.02 0 0.0 0.0% 
Total 42 100.0% 1.20 2 100.0% 4.8% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
D. Table 6-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2005 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 31 52.5 1.71 3 60.0 5.08% 
Male 28 47.5 1.53 2 40.0 3.39% 
Total 59 100.0 1.62 5 100.0 8.47% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
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D. Table7-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2006 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 23 48.9 1.23 1 33.3 2.1% 
Male 24 51.1 1.26 2 66.7 4.3% 
Total 47 100.0% 1.24 3 100.0% 6.4% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
D. Table 8-Cases & Deaths of Haemophilus influenzae in MC by Gender in 2007 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 21 46.7 1.09 0 0.0 0.0% 
Male 24 53.3 1.23 0 0.0 0.0% 
Total 45 100.0% 1.16 0 0.0% 0.0% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
 
D. Table 9-Case & Deaths of Haemophilus influenzae in MC by Gender in 2000-
2007 
 Cases Deaths 
Gender # % Rate* # %  
Case Fatality Rate** 
Female 181 52.3 1.31 11 61.1 3.18% 
Male 165 47.7 1.18 7 38.9 2.02% 
Total 346 100.0% 1.25 18 100.0% 5.20% 
*Individual gender rates were calculated using gender subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
 
 
 
 
 
 
    
40
E.  Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2000-2007 
 
E. Table 1-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2000 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4 13  39.4 5.37 0 0.0 0.0% 
5-9 3  9.1 1.26 0 0.0 0.0% 
10-14 0  0.0 0 0 0.0 0.0% 
15-19 1  3.0 .47 0 0.0 0.0% 
20-24 1  3.0 .45 0 0.0 0.0% 
25-34 0  0.0 0 0 0.0 0.0% 
35-44 0  0.0 0 0 0.0 0.0% 
45-54 1 3.0 .27 0 0.0 0.0% 
55-59 1 3.0 .75 0 0.0 0.0% 
60-64 2 6.1 1.86 0 0.0 0.0% 
65-74 5 15.2 2.65 0 0.0 0.0% 
75-84 4 12.1 3.08 0 0.0 0.0% 
85+ 2 6.1 4.98 0 0.0 0.0% 
Total 33 100.0% 1.07 0 0.0% 0.0% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
E. Table 2-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2001 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4 7 20.0 2.7 0 0.0 0.0% 
5-9 0 0.0 0 0 0.0 0.0% 
10-14 1 2.9 .43 0 0.0 0.0% 
15-19 0 0.0 0 0 0.0 0.0% 
20-24 1 2.9 .42 0 0.0 0.0% 
25-34 0 0.0 0 0 0.0 0.0% 
35-44 1 2.9 .20 0 0.0 0.0% 
45-54 7 20.0 1.79 0 0.0 0.0% 
55-59 2 5.7 1.40 0 0.0 0.0% 
60-64 4 11.4 3.52 1 100.0 2.9% 
65-74 4 11.4 2.11 0 0.0 0.0% 
75-84 4 11.4 2.98 0 0.0 0.0% 
85+ 4 11.4 9.27 0 0.0 0.0% 
Total 35 100.0% 1.09 1 100.0% 2.9% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
    
41
E. Table  3-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2002 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4 16  34.8 6.03 1 50.0 2.2% 
5-9 2  4.4 .79 0 0.0 0.0% 
10-14 1  2.2 .41 0 0.0 0.0% 
15-19 0  0.0 0 0 0.0 0.0% 
20-24 2  4.4 .81 0 0.0 0.0% 
25-34  3 6.7 .58 0 0.0 0.0% 
35-44  1 2.2 .20 0 0.0 0.0% 
45-54 3 6.5 .74 0 0.0 0.0% 
55-59 1 2.2 .64 0 0.0 0.0% 
60-64 4 8.7 3.3 0 0.0 0.0% 
65-74 7 15.2 3.7 1 50.0 2.2% 
75-84 2 4.4 1.5 0 0.0 0.0% 
85+ 4 8.7 9 0 0.0 0.0% 
Total 46 100.0% 1.4 2 100.0% 4.4% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
E. Table 4-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2003 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4 5  12.8 1.89 0 0.0 0.0% 
5-9  2 5.1 .80 0 0.0 0.0% 
10-14  0 0.0 0 0 0.0 0.0% 
15-19  0 0.0 0 0 0.0 0.0% 
20-24  4 10.3 1.62 0 0.0 0.0% 
25-34  1 2.6 .19 0 0.0 0.0% 
35-44  1 2.6 .19 0 0.0 0.0% 
45-54 5 12.8 1.19 1 20.0 2.56% 
55-59 3 7.7 1.80 0 0.0 0.0% 
60-64 3 7.7 2.31 0 0.0 0.0% 
65-74 4 10.3 2.06 1 20.0 2.56% 
75-84 4 10.3 2.87 0 0.0 0.0% 
85+ 7 18.0 14.53 3 60.0 7.69% 
Total 39 100.0% 1.15 5 100.0% 12.82% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
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E. Table 5-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2004 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4  10 23.8 3.47 0 0.0 0.0% 
5-9  2 4.8 .76 0 0.0 0.0% 
10-14  1 2.4 .39 0 0.0 0.0% 
15-19  1 2.4 .43 0 0.0 0.0% 
20-24  2 4.8 .80 0 0.0 0.0% 
25-34  0 0.0 0 0 0.0 0.0% 
35-44  3 7.1 .58 0 0.0 0.0% 
45-54 5 11.9 1.14 1 50.0 2.4% 
55-59 2 4.8 1.12 0 0.0 0.0% 
60-64 2 4.8 1.44 0 0.0 0.0% 
65-74 5 11.9 2.52 1 50.0 2.4% 
75-84 6 14.3 4.23 0 0.0 0.0% 
85+ 3 7.1 5.91 0 0.0 0.0% 
Total 42 100.0% 1.20 2 100.0% 4.8% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
E. Table 6-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2005 
 Cases Deaths 
Age 
(in years) 
# % Rate* # % Case Fatality Rate** 
0-4  14 23.7 4.60 2 40.0 3.39% 
5-9  1 1.7 .37 0 0.0 0.0% 
10-14  0 0.0 0 0 0.0 0.0% 
15-19  1 1.7 .41 0 0.0 0.0% 
20-24  1 1.7 .40 0 0.0 0.0% 
25-34  2 3.4 .35 0 0.0 0.0% 
35-44  3 5.1 .56 0 0.0 0.0% 
45-54 6 10.2 1.30 1 20.0 1.69% 
55-59 4 6.8 2.08 0 0.0 0.0% 
60-64 3 5.1 2.02 0 0.0 0.0% 
65-74 5 8.5 2.45 0 0.0 0.0% 
75-84 13 22.0 8.96 2 40.0 3.39% 
85+ 6 10.2 11.07 0 0.0 0.0% 
Total 59 100.0% 1.62 5 100.0% 8.47% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
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E. Table 7-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2006 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4 15  31.9 4.77 1 33.3 2.1% 
5-9  3 6.4 1.05 0 0.0 0.0% 
10-14  0 0.0 0 0 0.0 0.0% 
15-19  1 2.1 .40 0 0.0 0.0% 
20-24  2 4.3 .80 0 0.0 0.0% 
25-34  0 0.0 0 0 0.0 0.0% 
35-44  1 2.1 .18 0 0.0 0.0% 
45-54 5 10.6 1.03 0 0.0 0.0% 
55-59 3 6.4 1.46 1 33.3 2.1% 
60-64 1 2.1 .64 0 0.0 0.0% 
65-74 7 14.9 3.30 1 33.3 2.1% 
75-84 5 10.6 3.40 0 0.0 0.0% 
85+ 4 8.5 6.89 0 0.0 0.0% 
Total 47 100.0% 1.24 3 100.0% 6.3% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
 
 
E. Table 8-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2007 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4  11 24.4 3.40 0 0.0 0.0% 
5-9  4 8.9 1.36 0 0.0 0.0% 
10-14  0 0.0 0 0 0.0 0.0% 
15-19  0 0.0 0 0 0.0 0.0% 
20-24  1 2.2 .40 0 0.0 0.0% 
25-34  1 2.2 .17 0 0.0 0.0% 
35-44  4 8.9 .71 0 0.0 0.0% 
45-54 2 4.4 .40 0 0.0 0.0% 
55-59 3 6.7 1.44 0 0.0 0.0% 
60-64 4 8.9 2.35 0 0.0 0.0% 
65-74 6 13.3 2.70 0 0.0 0.0% 
75-84 5 11.1 3.37 0 0.0 0.0% 
85+ 4 8.9 6.48 0 0.0 0.0% 
Total 45 100.0% 1.03 0 0.0% 0.0% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
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E. Table 9-Cases & Deaths of Haemophilus influenzae in MC by Agegroup in 2000-
2007 
 Cases Deaths 
Age 
(in years) 
# % Rate* # %  
Case Fatality Rate** 
0-4  91 26.3 4.01 4 22.2 1.16% 
5-9  17 4.9 .81 0 0.0 0.0% 
10-14  3 .9 .15 0 0.0 0.0% 
15-19  4 1.2 .21 0 0.0 0.0% 
20-24  14 4.1 .72 0 0.0 0.0% 
25-34  7 2.0 .16 0 0.0 0.0% 
35-44  14 4.1 .34 0 0.0 0.0% 
45-54 34 9.8 .98 3 16.7 .87% 
55-59 19 5.5 1.37 1 5.6 .29% 
60-64 23 6.7 2.11 1 5.6 .29% 
65-74 43 12.4 2.69 4 22.2 1.16% 
75-84 43 12.4 4.10 2 11.1 .58% 
85+ 34 9.8 8.47 3 16.7 .87% 
Total 346 100.0% 1.25 18 100.0% 5.20% 
*Individual agegroup rates were calculated using agegroup subpopulation; the total rate is based on the   
    total population. 
**Case Fatality Rates calculated using total number of cases. 
 
 
F.  Population Estimates for Maricopa County, 2000-2007 
 
F. Table 1-MC Population for years 2000-2007, by Race/Ethnicity per U.S. Census 
Bureau 
Year Race/Ethnicity 
White 
 
Hispanic Black Native 
Am./Alaskan 
Native  
Asian/Island 
Pacific 
Other Total 
2000 2,046,444 763,341 110,195 47,60 69,928 34,634 3,072,149 
2001 2,091,450 829,443 115,913 50,730 76,137 37,171 3,200,844 
2002 2,124,085 882,774 121,056 51,961 81,286 39,263 3,300,425 
2003 2,154,117 932,070 125,760 53,190 85,813 41,566 3,392,516 
2004 2,195,688 985,790 132,286 54,938 91,200 44,241 3,504,143 
2005 2,248,480 1,052,764 141,055 57,820 98,886 47,564 3,646,569 
2006 2,286,987 1,121,985 150,801 60,185 107,778 50,862 3,778,598 
2007 2,309,547 1,182,656 158,688 61,605 114,246 53,439 3,880,181 
2000-
2007 
17,456,798 7,750,823 1,055,754 438,036 725,274 348,740 27,775,425 
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F. Table 2-MC Population for Years 2000-2007, by Gender per U.S. Census Bureau 
Gender Year 
2000 2001 2002 2003 2004 2005 2006 2007 
Female 1,535,676 1,597,427 1,645,438 1,690,266 1,743,562 1,813,086 1,876,914 1,926,105 
Male 1,536,473 1,603,417 1,654,987 1,702,250 1,760,581 1,833,483 1,901,684 1,954,076 
Total 3,072,149 3,200,844 3,300,425 3,392,516 3,504,143 3,646,569 3,778,598 3,880,181 
 
 
F. Table 3- MC Population for Years 2000-2007, by Gender per U.S. Census Bureau 
 
Gender Years 
2000-2007 
Female 13,828,474 
Male 13,946,951 
Total 27,775,425 
 
 
 
 
 
 
F. Table 4-MC Population for years 2000-2007 by Age Per U.S. Census Bureau 
Age 
(In 
years) 
Year 
2000 2001 2002 2003 2004 2005 2006 2007 
0-4  241,974 255,183 265,178 276,474 288,381 304,037 314,742 323,861 
5-9 238,222 245,505 251,549 255,739 262,619 272,035 285,086 294,409 
10-14 222,056 234,051 242,454 250,143 257,625 266,011 273,966 279,646 
15-19 214,672 216,789 219,526 224,296 231,816 242,268 251,957 260,467 
20-24 224,444 239,588 246,882 249,012 249,274 249,676 249,235 248,418 
25-34 488,329 504,371 519,991 532,429 549,726 569,515 585,795 595,579 
35-44 475,907 490,375 499,483 506,601 518,979 537,454 555,797 564,758 
45-54 366,464 391,744 405,171 420,438 437,632 461,087 481,996 501,230 
55-59 133,812 142,527 156,534 166,442 178,257 192,169 205,878 208,977 
60-64 107,290 113,743 120,573 129,762 139,015 148,792 157,040 170,461 
65-74 188,816 189,548 191,064 193,823 198,373 204,272 212,154 222,478 
75-84 130,036 134,289 136,853 139,200 141,770 145,039 146,867 148,197 
85+ 40,127 43,131 45,167 48,157 50,676 54,214 58,085 61,700 
Total 3,072,149 3,200,844 3,300,425 3,392,516 3,504,143 3,646,569 3,778,598 3,880,181 
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F. Table 5-MC Population for years 2000-2007 by Age Per U.S. Census Bureau 
Age ( in Years) Years 
2000-2007 
0-4 2,269,830 
5-9 2,105,164 
10-14 2,025,952 
15-19 1,861,791 
20-24 1,956,529 
25-34 4,345,735 
35-44 4,149,354 
45-54 3,465,762 
55-59 1,384,596 
60-64 1,086,676 
65-74 1,600,528 
75-84 1,122,251 
85+ 401,257 
Total 27,775,425 
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F. Table 6-MC Population, 2000, by Age and Race Per U.S. Census Bureau 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 119,413 97,104 9,544 4,558 5,047 6,308 241,974 
5-9 125,584 87,461 10,546 4,730 4,751 5,150 238,222 
10-14 126,795 71,987 10,354 4,469 4,393 4,058 222,056 
15-19 121,915 71,357 9,224 4,417 4,443 3,316 214,672 
20-24 119,951 82,685 8,267 5,259 5,558 2,724 224,444 
25-29 140,908 81,013 8,991 5,053 8,274 2,454 246,693 
30-34 150,278 68,174 9,282 4,358 7,510 2,034 241,636 
35-39 168,355 56,866 9,786 3,963 6,723 1,973 247,666 
40-44 165,771 42,846 9,000 3,166 5,796 1,662 228,241 
45-49 147,542 31,450 7,033 2,355 4,799 1,325 194,504 
50-54 136,761 23,287 5,213 1,848 3,819 1,032 171,960 
55-59 110,035 15,646 3,658 1,139 2,588 746 133,812 
60-64 89,910 10,957 2,900 857 2,086 580 107,290 
65-69 84,156 8,325 2,214 521 1,626 434 97,276 
70-74 81,783 6,227 1,664 359 1,171 336 91,540 
75-79 71,992 4,040 1,145 279 682 234 78,372 
80-84 48,071 2,217 725 143 376 132 51,664 
85+ 37,224 1,699 649 133 286 136 40,127 
TOTAL 2,046,444 763,341 110,195 47,607 69,928 34,634 3,072,149 
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F. Table 7-MC Population, 2001, by Age and Race Per U.S. Census Bureau 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 121,627 105,728 10,352 4,916 5,671 6,889 255,183 
5-9 124,878 94,043 10,735 4,822 5,197 5,830 245,505 
10-14 129,921 78,998 10,910 4,887 4,804 4,531 234,051 
15-19 122,849 71,500 9,747 4,477 4,647 3,569 216,789 
20-24 126,994 89,431 8,817 5,756 5,588 3,002 239,588 
25-29 134,819 89,155 9,197 5,225 8,664 2,465 249,525 
30-34 154,435 75,460 9,535 4,740 8,509 2,167 254,846 
35-39 165,105 62,274 10,058 4,138 7,206 1,940 250,721 
40-44 170,940 47,751 9,524 3,466 6,284 1,689 239,654 
45-49 153,681 34,956 7,453 2,473 5,281 1,379 205,223 
50-54 147,053 26,180 5,866 2,048 4,333 1,041 186,521 
55-59 116,137 17,511 3,882 1,262 2,973 762 142,527 
60-64 94,696 12,098 3,065 950 2,325 609 113,743 
65-69 83,881 8,813 2,372 586 1,762 440 97,854 
70-74 81,367 6,635 1,712 364 1,290 326 91,694 
75-79 72,362 4,450 1,215 312 826 247 79,412 
80-84 50,794 2,542 808 161 436 136 54,877 
85+ 39,911 1,918 665 147 341 149 43,131 
TOTAL 2,091,450 829,443 115,913 50,730 76,137 37,171 3,200,844 
 
F. Table 8- MC Population, 2002, by Age and Race Per U.S. Census Bureau 
 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 123,416 112,615 10,876 5,076 6,152 7,043 265,178 
5-9 124,653 99,304 10,931 4,810 5,655 6,196 251,549 
10-14 131,472 84,673 11,375 4,979 5,065 4,890 242,454 
15-19 123,926 72,420 10,155 4,548 4,755 3,722 219,526 
20-24 130,263 92,792 9,238 5,650 5,694 3,245 246,882 
25-29 133,466 95,610 9,394 5,454 8,912 2,564 255,400 
30-34 155,953 82,042 9,984 4,811 9,434 2,367 264,591 
35-39 160,734 66,382 10,117 4,101 7,517 1,960 250,811 
40-44 174,407 51,955 9,959 3,741 6,775 1,835 248,672 
45-49 159,376 38,256 8,025 2,602 5,672 1,448 215,379 
50-54 147,511 28,140 6,292 2,106 4,642 1,101 189,792 
55-59 127,243 19,406 4,260 1,420 3,350 855 156,534 
60-64 100,095 13,102 3,242 956 2,501 677 120,573 
65-69 84,278 9,472 2,573 626 1,983 460 99,392 
70-74 80,803 6,934 1,778 405 1,398 354 91,672 
75-79 72,065 4,793 1,304 325 887 251 79,625 
80-84 52,707 2,814 844 189 529 145 57,228 
85+ 41,717 2,064 709 162 365 150 45,167 
TOTAL 2,124,085 882,774 121,056 51,961 81,286 39,263 3,300,425 
    
49
F. Table 9-MC Population, 2003, by Age and Race Per U.S. Census Bureau 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 125,547 120,296 11,370 5,244 6,694 7,323 276,474 
5-9 124,379 102,909 11,139 4,777 5,935 6,600 255,739 
10-14 132,065 90,712 11,768 5,092 5,368 5,138 250,143 
15-19 125,888 74,315 10,612 4,691 4,822 3,968 224,296 
20-24 131,903 92,767 9,744 5,508 5,637 3,453 249,012 
25-29 133,580 101,766 9,427 5,594 9,008 2,778 262,153 
30-34 154,760 87,521 10,314 5,013 10,195 2,473 270,276 
35-39 157,137 70,925 10,137 4,149 8,006 2,002 252,356 
40-44 175,335 55,804 10,341 3,819 7,009 1,937 254,245 
45-49 165,356 41,413 8,428 2,737 6,108 1,590 225,632 
50-54 149,482 30,209 6,709 2,178 5,040 1,188 194,806 
55-59 134,416 21,250 4,631 1,551 3,671 923 166,442 
60-64 107,405 14,384 3,540 1,010 2,655 768 129,762 
65-69 86,461 10,073 1,271 702 2,189 1,912 102,608 
70-74 79,793 7,268 1,903 408 1,502 341 91,215 
75-79 72,261 5,118 1,359 348 989 272 80,347 
80-84 54,046 2,987 899 200 556 165 58,853 
85+ 44,303 2,353 756 169 429 147 48,157 
TOTAL 2,154,117 932,070 124,348 53,190 85,813 42,978 3,392,516 
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F. Table 10-MC Population, 2004, by Age and Race Per U.S. Census Bureau 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 127,998 127,931 12,093 5,481 7,269 7,609 288,381 
5-9 125,262 107,870 11,448 4,864 6,202 6,973 262,619 
10-14 132,327 96,472 12,342 5,167 5,740 5,577 257,625 
15-19 128,754 77,846 11,128 4,888 5,007 4,193 231,816 
20-24 132,431 91,657 10,434 5,378 5,720 3,654 249,274 
25-29 138,200 107,745 9,922 5,821 9,169 3,154 274,011 
30-34 152,773 93,769 10,701 5,075 10,802 2,595 275,715 
35-39 155,720 75,339 10,311 4,206 8,597 2,077 256,250 
40-44 177,828 60,467 10,766 4,046 7,625 1,997 262,729 
45-49 170,123 45,013 9,025 2,912 6,455 1,708 235,236 
50-54 153,634 32,584 7,156 2,314 5,400 1,308 202,396 
55-59 142,787 23,526 5,116 1,706 4,103 1,019 178,257 
60-64 114,730 15,772 3,762 1,050 2,903 798 139,015 
65-69 89,569 10,811 2,837 790 2,343 580 106,930 
70-74 79,177 7,706 2,060 463 1,663 374 91,443 
75-79 71,946 5,439 1,418 356 1,088 289 80,536 
80-84 55,973 3,258 964 218 628 193 61,234 
85+ 46,456 2,585 803 203 486 143 50,676 
TOTAL 2,195,688 985,790 132,286 54,938 91,200 44,241 3,504,143 
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F. Table 11-MC Population, 2005, by Age and Race Per U.S. Census Bureau 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 131,677 136,732 13,096 6,168 8,239 8,125 304,037 
5-9 126,513 114,259 12,201 4,989 6,598 7,475 272,035 
10-14 132,779 102,902 12,887 5,242 6,216 5,985 266,011 
15-19 131,494 83,782 11,850 5,215 5,339 4,588 242,268 
20-24 133,199 90,496 10,839 5,350 5,921 3,871 249,676 
25-29 144,183 114,068 10,949 6,159 9,421 3,407 288,187 
30-34 149,574 101,693 10,804 5,212 11,348 2,697 281,328 
35-39 158,240 81,547 10,988 4,348 9,693 2,268 267,084 
40-44 178,687 65,745 11,160 4,242 8,380 2,156 270,370 
45-49 176,527 49,750 9,890 3,130 7,018 1,806 248,121 
50-54 159,798 35,640 7,776 2,462 5,843 1,447 212,966 
55-59 152,499 26,202 5,680 1,954 4,685 1,149 192,169 
60-64 121,749 17,584 4,195 1,125 3,250 889 148,792 
65-69 93,149 11,692 3,079 862 2,584 624 111,990 
70-74 79,048 8,314 2,192 507 1,812 409 92,282 
75-79 72,515 5,889 1,570 369 1,284 306 81,933 
80-84 57,360 3,553 1,024 273 691 205 63,106 
85+ 49,489 2,916 875 213 564 157 54,214 
TOTAL 2,248,480 1,052,764 141,055 57,820 98,886 47,564 3,646,569 
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F. Table 12-MC Population, 2006, by Age and Race Per U.S. Census Bureau 
 White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 132,260 144,480 14,056 6,408 8,940 8,598 314,742 
5-9 128,715 122,574 13,338 5,190 7,482 7,787 285,086 
10-14 132,488 109,537 13,365 5,242 6,778 6,556 273,966 
15-19 133,301 89,898 12,591 5,535 5,703 4,929 251,957 
20-24 132,580 89,518 11,555 5,283 6,177 4,122 249,235 
25-29 149,249 119,813 11,751 6,471 9,771 3,678 300,733 
30-34 144,085 109,317 11,405 5,291 12,156 2,808 285,062 
35-39 162,766 88,738 11,506 4,668 10,953 2,499 281,130 
40-44 175,993 71,214 11,800 4,369 9,049 2,242 274,667 
45-49 181,341 54,447 10,639 3,374 7,667 1,956 259,424 
50-54 164,687 38,961 8,310 2,556 6,451 1,607 222,572 
55-59 161,916 28,900 6,446 2,133 5,236 1,247 205,878 
60-64 127,309 19,346 4,537 1,230 3,656 962 157,040 
65-69 97,665 12,840 3,333 934 2,833 695 118,300 
70-74 79,506 8,907 2,411 578 1,996 456 93,854 
75-79 72,423 6,320 1,670 377 1,437 318 82,545 
80-84 57,961 3,889 1,116 300 826 230 64,322 
85+ 52,742 3,286 972 246 667 172 58,085 
Total 2,286,987 1,121,985 150,801 60,185 107,778 50,862 3,778,598 
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F. Table 13-MC Population, 2007, by Age and Race Per U.S. Census Bureau 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 133,134 151,414 14,712 6,310 9,352 8,939 323,861 
5-9 129,505 129,287 14,216 5,352 8,100 7,949 294,409 
10-14 131,286 115,090 13,762 5,225 7,304 6,979 279,646 
15-19 134,089 95,991 13,338 5,684 6,044 5,321 260,467 
20-24 131,584 89,365 11,954 5,329 6,021 4,165 248,418 
25-29 150,746 122,531 12,595 6,400 9,893 3,996 306,161 
30-34 141,215 115,483 11,684 5,587 12,548 2,901 289,418 
35-39 163,131 95,446 12,248 4,784 12,091 2,675 290,375 
40-44 170,559 75,747 11,910 4,374 9,497 2,296 274,383 
45-49 184,165 59,087 11,265 3,659 8,237 2,102 268,515 
50-54 169,743 42,643 8,954 2,713 6,945 1,717 232,715 
55-59 161,787 31,104 6,954 2,193 5,637 1,302 208,977 
60-64 137,642 21,361 4,931 1,411 4,060 1,056 170,461 
65-69 103,962 13,997 3,539 955 3,046 778 126,277 
70-74 80,592 9,623 2,639 625 2,237 485 96,201 
75-79 72,468 6,638 1,741 426 1,556 351 83,180 
80-84 58,124 4,233 1,211 298 914 237 65,017 
85+ 55,815 3,616 1,035 280 764 190 61,700 
TOTAL 2,309,547 1,182,656 158,688 61,605 114,246 53,439 3,880,181 
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F. Table 14-MC Population, 2000-2007, by Age and Race Per U.S. Census Bureau 
  White Hispanic Black 
Native 
American 
Asian/Pacific 
Islander Other Total 
0-4 1,015,072 996,300 96,099 44,161 57,364 60,834 2,269,830 
5-9 1,009,489 857,707 94,554 39,534 49,920 53,960 2,105,164 
10-14 1,049,133 750,371 96,763 40,303 45,668 43,714 2,025,952 
15-19 1,022,216 637,109 88,645 39,455 40,760 33,606 1,861,791 
20-24 1,038,905 718,711 80,848 43,513 46,316 28,236 1,956,529 
25-29 1,125,151 831,701 82,226 46,177 73,112 24,496 2,182,863 
30-34 1,203,073 733,459 83,709 40,087 82,502 20,042 2,162,872 
35-39 1,291,188 597,517 85,151 34,357 70,786 17,394 2,096,393 
40-44 1,389,520 471,529 84,460 31,223 60,415 15,814 2,052,961 
45-49 1,338,111 354,372 71,758 23,242 51,237 13,314 1,852,034 
50-54 1,228,669 257,644 56,276 18,225 42,473 10,441 1,613,728 
55-59 1,106,820 183,545 40,627 13,358 32,243 8,003 1,384,596 
60-64 893,536 124,604 30,172 8,589 23,436 6,339 1,086,676 
65-69 723,121 86,023 21,218 5,976 18,366 5,923 860,627 
70-74 642,069 61,614 16,359 3,709 13,069 3,081 739,901 
75-79 578,032 42,687 11,422 2,792 8,749 2,268 645,950 
80-84 435,036 25,493 7,591 1,782 4,956 1,443 476,301 
85+ 367,657 20,437 6,464 1,553 3,902 1,244 401,257 
TOTAL 17,456,798 7,750,823 1,054,342 438,036 725,274 350,152 27,775,425 
 
 
G.  U.S. population Estimates for 2000-2007  
 
G. Table 1-U.S. Population for Years 2000-2007 Per U.S. Census Bureau 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YEAR U.S. Population 
2000 282,158,336 
2001 284,915,024 
2002 287,501,476 
2003 289,985,771 
2004 292,805,643 
2005 295,583,436 
2006 298,442,420 
2007 301,279,593 
Total 2,332,671,699 
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